What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?-Reference-Cited by-同舟云学术

What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?

Published:2014-11 Issue:2 Volume:92 Page:83-106
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Capdevila Jaume,Carrato Alfredo,Tabernero Josep,Grande Enrique

Funder

Boehringer Ingelheim Spain

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference156 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Colorectal cancer;Cunningham;Lancet,2010

3. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

4. A review of oxaliplatin and its clinical use in colorectal cancer;Grothey;Expert Opin Pharmacother,2004

5. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies;Bioorganic Chemistry;2024-11

2. A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer;JNCI Cancer Spectrum;2024-04-30

3. Boosting immune responses in lung tumor immune microenvironment: A comprehensive review of strategies and adjuvants;International Reviews of Immunology;2024-03-25

4. Biological factors driving colorectal cancer metastasis;World Journal of Gastrointestinal Oncology;2024-02-15

5. Signaling Pathway and Small-Molecule Drug Discovery of FGFR: A Comprehensive Review;Frontiers in Chemistry;2022-04-14